| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 19.149 | 23.350 | 33.882 | 42.270 | 39.574 | 47.073 | 51.108 | 65.508 | 73.413 |
| Total Income - EUR | - | 19.149 | 23.350 | 33.882 | 42.270 | 41.806 | 47.074 | 51.109 | 67.363 | 75.936 |
| Total Expenses - EUR | - | 17.879 | 19.325 | 18.948 | 20.351 | 26.480 | 22.438 | 23.883 | 35.153 | 53.198 |
| Gross Profit/Loss - EUR | - | 1.270 | 4.025 | 14.934 | 21.920 | 15.326 | 24.636 | 27.226 | 32.210 | 22.739 |
| Net Profit/Loss - EUR | - | 1.075 | 3.790 | 14.591 | 21.495 | 14.957 | 24.228 | 26.725 | 31.633 | 20.646 |
| Employees | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Favcom Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 17.445 | 17.134 | 18.292 | 18.230 | 17.936 | 16.777 | 16.394 | 63.383 | 53.537 |
| Current Assets | - | 4.595 | 8.514 | 21.517 | 25.482 | 21.117 | 38.353 | 29.994 | 43.316 | 13.642 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.944 | 1.832 | 2.742 | 3.830 | 436 | 3.822 | 13.758 | 29.949 | 962 |
| Cash | - | 2.651 | 6.682 | 18.774 | 21.651 | 20.681 | 34.531 | 16.236 | 13.367 | 12.680 |
| Shareholders Funds | - | 1.120 | 4.890 | 19.391 | 23.653 | 17.488 | 35.768 | 26.773 | 33.756 | 31.925 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 20.976 | 20.934 | 20.640 | 20.212 | 21.699 | 19.582 | 19.759 | 56.291 | 21.368 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.907 | 14.291 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Favcom Med Srl